Article

Pacemaker After TAVR Reduces Heart Strain

Author(s):

Conduction abnormalities in patients who undergo transcatheter aortic valve replacement and then need a pacemaker can be worrisome. A Pittsburghm PA team looked at how these patients fared.

Conduction abnormalities in patients who undergo transcatheter aortic valve replacement (TAVR) and then need a pacemaker can be worrisome. A Pittsburgh PA team looked at how these patients fared.

In a study to be presented at the American College of Cardiology 65th Scientific Sessions & Expo in Chicago, IL, April 2, University of Pittsburgh researchers Matsataka Sugahara and colleagues looked at 389 consecutive TAVR patients and selected those requiring a permanent pacemaker.

They evaluated the patients before TAVR, then at one month and one year after TAVR.

There were 40 patients in the group studied, but two died and three had upgrades to CRT.

Of the remaining 35 patients, 20 still needed the pacemaker at one year and 15 had recovery of conduction.

Pacemaker dependent patients more frequently had a right bundle branch block prior to TAVR. There was a significant difference in global longitudinal strain over time in the pacemaker dependent patients. These patients showed a steady decline in GLS.

"Conduction abnormalities after TAVR requiring a pacemaker are uncommon but important," the team concluded. The good news is that "Pacemaker dependency after TAVR was associated with a significant decrease in myocardial strain over time."

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
A. Sidney Barritt, MD | Credit: UNC School of Medicine
© 2024 MJH Life Sciences

All rights reserved.